Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5

被引:10
|
作者
Zombori, Tamas [1 ]
Cserni, Gabor [1 ,2 ]
机构
[1] Univ Szeged, Dept Pathol, Fac Med, Allomas U 1, H-6725 Szeged, Hungary
[2] Bacs Kiskun Cty Teaching Hosp, Dept Pathol, Kecskemet, Hungary
关键词
Basal-like; Triple negative breast cancer; GATA-3; Mammaglobin; GCDFP-15; NY-BR-1; DISEASE FLUID PROTEIN-15; DIFFERENTIATION ANTIGEN NY-BR-1; UTEROGLOBIN GENE FAMILY; FEMALE GENITAL-TRACT; GATA3; IMMUNOHISTOCHEMISTRY; ESTROGEN-RECEPTOR; CLINICOPATHOLOGICAL ANALYSIS; MAMMAGLOBIN EXPRESSION; DIAGNOSTIC UTILITY; IDENTIFICATION;
D O I
10.1007/s12253-017-0246-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estrogen and progesterone receptors are possible markers for suggesting a mammary origin of metastatic carcinoma, but are useless in cases of triple negative breast cancers (TNBC). Five other potential markers of breast origin were investigated on tissue microarrays in a series of TNBCs showing keratin 5 expression, consistent with a basal-like phenotype. GATA-3 staining was observed in 82 of 115 triple negative cases (71.3%) including 23 cases with > 5% staining. Mammaglobin staining was detected in 30 cases (26.0%) including 12 with > 5% staining. GCDFP-15 was seen in 23 cases (20.0%) including 9 with > 5% staining. NY-BR-1 positivity was present in 7 cases (6.0%) including 3 patients with > 5% staining. BCA-225 staining was observed in 74 cases (64.3%); however this latter marker lacks also specificity owing to the reported widespread staining in other malignancies. GATA-3, mammaglobin and GCDFP-15 coexpression was seen in one case (0.9%), whereas GATA-3 and mammaglobin or mammaglobin and GCDFP-15 coexpression was present in 2 and 2 cases (1.7%), respectively. Using at least 5% staining as cut-off, the expression of any of the last 4 markers was 34.7%. The expression of GATA-3, mammaglobin, GCDFP-15 and NY-BR-1 is lower in TNBC-s than in breast carcinomas in general, and this may be even lower in basal-like carcinomas. Although these markers are not fully specific, by using them, a subset of basal-like TNBC-s can be identified as of mammary origin. However, a substantial proportion will not show any staining with any of these markers.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 50 条
  • [1] Immunohistochemical analysis of the expression of breast markers in basal-like breast carcinomas defined as triple negative cancers expressing keratin 5
    Zombori, T.
    Cserni, G.
    VIRCHOWS ARCHIV, 2017, 471 : S23 - S23
  • [2] Basal-like immunophenotype in triple negative breast carcinomas
    Kapicl, Ivkovic T.
    Usaj, Knezevic S.
    Panjkovic, M.
    Nikin, Z.
    Plzak, A.
    VIRCHOWS ARCHIV, 2009, 455 : 105 - 105
  • [3] Triple Negative Breast Cancers: Outcome Correlation with Immunohistochemical Expression of Basal Markers
    Tan, P. H.
    Thike, A.
    Cheok, P. Y.
    LABORATORY INVESTIGATION, 2010, 90 : 74A - 75A
  • [4] Triple Negative Breast Cancers: Outcome Correlation with Immunohistochemical Expression of Basal Markers
    Tan, P. H.
    Thike, A.
    Cheok, P. Y.
    MODERN PATHOLOGY, 2010, 23 : 74A - 75A
  • [5] Expression of basal-like markers in male breast cancers
    Flanagan, M. B.
    Bhargava, R.
    Dobbs, D. J.
    Thull, D.
    Chivukula, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S223 - S223
  • [6] Immunohistochemical Characteristics of Triple Negative/Basal-like Breast Cancer
    Pala, Emel Ebru
    Bayol, Umit
    Cumurcu, Suheyla
    Keskin, Elif
    TURKISH JOURNAL OF PATHOLOGY, 2012, 28 (03) : 238 - 244
  • [7] Nestin is expressed in basal-like and triple negative breast cancers
    Parry, S.
    Savage, K.
    Marchio, C.
    Reis-Filho, J. S.
    JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (09) : 1045 - 1050
  • [8] Discrepancy between triple negative phenotype and basal-like tumor: an immunohistochemical analysis based on 150 "triple-negative" breast cancers
    Conforti, R.
    Bidard, F. C.
    Michiels, S.
    Boulet, T.
    Tomasic, G.
    Mathieu, M. C.
    Delaloge, S.
    Andre, F.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S135 - S136
  • [9] Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
    Britta Weigelt
    Bas Kreike
    Jorge S. Reis-Filho
    Breast Cancer Research and Treatment, 2009, 117 : 273 - 280
  • [10] Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
    Weigelt, Britta
    Kreike, Bas
    Reis-Filho, Jorge S.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (02) : 273 - 280